Importantly, our immunofluorescence data objectively quantified the differential protein expression levels in IBC samples compared to non-IBC, supporting the proposed link between TLR4, AGER, and IBC pathogenesis. This evidence concerns the gene TLR4 and inflammatory breast carcinoma.